AESC and Jinko Asset Sales Signal Broader Restructuring in US Clean Energy Manufacturing Petco WOOF Crushes Q1 2026 Estimates EPS 004 Tops Views Is Expedia Group EXPE Still a Buy After 070 Rally 20260515 US Economy Posts 2 Growth in Q1 2026 as Recovery from Federal Shutdown Continues Geopolitical Risks Loom Charter Communications Proposes Enhanced Buyout of Liberty Broadband in Strategic Consolidation SP 500 Creeps Higher as Healthcare and Tech Power Gains in Mixed Session Kevin Warsh Set to Assume Federal Reserve Chairmanship on Friday Analysts Assess Lowes Companies Amid Housing Market Headwinds SpaceX and OpenAI IPOs Could Amplify AI Valuation Concerns Analysts Suggest US Treasury Yields Decline as Bond Market Volatility Eases RCAT Q1 2026 Earnings Negative EPS Surprise as Strategic Initiatives Continue PMVP Q1 2026 Earnings Narrower Loss Slightly Beats Estimates as Development Advances Calix Inc Q1 2026 Earnings EPS Meets Estimates Amid Steady Execution CHAI Q4 2025 Earnings Massive Earnings Miss Highlights Ongoing Challenges CXW Q1 2026 Earnings CoreCivic Reports EPS Beat Stock Rises Harrow Inc HROW Q1 2026 Earnings Significant EPS Miss as Operating Losses Widen Mondelez International MDLZ Holds Steady Near Support as Consumer Staples Sector Attracts Defensive Flows ATI Inc ATI Edges Higher Testing Key Resistance Near 178 Public Policy Holding Company PPHC Slips 22 as Shares Test Key Support at 1097 LifeMD LFMD Gains Nearly 5 as Stock Approaches Key Resistance Level Guardforce AI GFAI Nears Key Support at 046 After Modest Decline Zillow Highlights Unusual Shifts in the Spring Housing Market Teleflex Incorporated TFX Q1 2026 Earnings EPS 139 Beats Estimates CytomX CTMX Crushes Q1 2026 Estimates EPS 010 Tops Views US Senate Unveils Landmark Crypto Bill Key Provisions Explained Latino GDP Surpasses Major Economies Ranking Fourth Largest Globally Despite Deportation Risks Consumer Price Index Rises 38 Annually in April Exceeding Expectations BTCS Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Company Faces Headwinds ALX Oncology ALXO Edges Higher Amid Modest Buying Interest Resistance at 206 in Focus